Fundraising Fox

Caroline Benn

Founder

Co-founder & CSO at LoQus23

Greater Cambridge Area

FoundedLoQus23

About

Caroline Benn is co-founder and Chief Scientific Officer of LoQus23 Therapeutics, where she works on small-molecule approaches targeting DNA damage repair mechanisms for repeat expansion diseases including Huntington's and Myotonic Dystrophy. She also serves as an Advisory Board Member at Alzheimer's Research UK. Her work focuses on drug discovery for neurodegenerative disease.

Co-founder & CSO at LoQus23

Intro paths

In turn, Caroline can intro founders to LoQus23's investors below.

Co-founders at LoQus23

DRDavid Reynolds
David ReynoldsCo-founder & CEO

Experience

  1. Alzheimer's Research UKAdvisory Board Membercurrent2022 — presentCambridge, United Kingdom
  2. UCLVisiting Professorcurrent2022 — presentLondon, United Kingdom
  3. LoQus23 Therapeutics LtdChief Scientific Officercurrent2020 — presentCambridge, England, United Kingdom
  4. Dementia Discovery FundScientific Strategist2018 — 202077 Kingsway, Holborn, London
  5. Astex Pharmaceuticals (US)Associate Director, CNS biology2016 — 2018Cambridge, United Kingdom
  6. PfizerSenior Principal Scientist2013 — 2016Cambridge, United Kingdom
  7. Pfizer Regenerative MedicinePrincipal Scientist2008 — 2013Cambridge UK
  8. King's College LondonPostdoctoral research fellow2007 — 2008
  9. Massacussetts General Hospital/Harvard Medical SchoolPostdoctoral Research Fellow2002 — 2007

Skills & more

Molecular Biology51Drug Discovery39Genetics14Stem Cells16Biomarkers16Sequencing7Regenerative Medicine3Neuroscience25In Vivo3Animal Models4Pharmacology4Biomarker Discovery3
+8 moreCell CultureIn VitroCell BiologyImmunohistochemistryCellNeurodegenerationBiochemistryWestern Blotting

Languages French

From Caroline's professional profile.

Frequently asked questions

Who is Caroline Benn?
Caroline Benn is co-founder and Chief Scientific Officer of LoQus23 Therapeutics, where she works on small-molecule approaches targeting DNA damage repair mechanisms for repeat expansion diseases including Huntington's and Myotonic Dystrophy. She also serves as an Advisory Board Member at Alzheimer's Research UK. Her work focuses on drug discovery for neurodegenerative disease.
Where does Caroline Benn work?
Caroline Benn is Co-founder & CSO of LoQus23.
What companies did Caroline Benn found?
Caroline Benn founded LoQus23.
Where did Caroline Benn go to school?
Caroline Benn studied at King's College London (PhD, Molecular Neurogenetics); University of Sussex (1st class BSc (Hons), Neuroscience); Gravesend Grammar School for Girls (GCSE, A-level).

Founder mafias

Same school

Shared employers